Protalix BioTherapeutics (PLX) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,381.02% |
| Dec 31, 2025 | 125.12% |
| Sep 30, 2025 | -170.33% |
| Jun 30, 2025 | -432.99% |
| Mar 31, 2025 | 96.18% |
| Dec 31, 2024 | -131.53% |
| Sep 30, 2024 | 744.64% |
| Jun 30, 2024 | -205.81% |
| Mar 31, 2024 | 10.11% |
| Dec 31, 2023 | 111.72% |
| Sep 30, 2023 | -282.87% |
| Jun 30, 2023 | -4.90% |
| Mar 31, 2023 | 148.82% |
| Dec 31, 2022 | 462.13% |
| Sep 30, 2022 | 74.68% |
| Jun 30, 2022 | 68.31% |
| Mar 31, 2022 | -178.03% |
| Dec 31, 2021 | 221.78% |
| Sep 30, 2021 | -265.35% |
| Jun 30, 2021 | 780.70% |
| Mar 31, 2021 | -66.00% |
| Dec 31, 2020 | -45.87% |
| Sep 30, 2020 | 192.57% |
| Jun 30, 2020 | -160.99% |
| Mar 31, 2020 | 1.89% |
| Dec 31, 2019 | 0.35% |
| Sep 30, 2019 | 30.28% |
| Jun 30, 2019 | 31.15% |
| Mar 31, 2019 | -95.08% |
| Dec 31, 2018 | -129.23% |
| Sep 30, 2018 | 265.92% |
| Jun 30, 2018 | 17.02% |
| Mar 31, 2018 | -155.12% |
| Dec 31, 2017 | 1,537.92% |
| Sep 30, 2017 | 90.84% |
| Jun 30, 2017 | 13.75% |
| Mar 31, 2017 | -228.53% |
| Dec 31, 2016 | 446.03% |
| Sep 30, 2016 | 71.82% |
| Jun 30, 2016 | -29.85% |
| Mar 31, 2016 | -123.51% |
| Dec 31, 2015 | 503.58% |
| Sep 30, 2015 | -118.93% |
| Jun 30, 2015 | 26.56% |
| Mar 31, 2014 | -651.05% |
| Dec 31, 2013 | -97.30% |
| Sep 30, 2013 | 760.04% |
| Jun 30, 2013 | 14.04% |
| Mar 31, 2013 | -750.73% |
| Dec 31, 2012 | 117.57% |
| Sep 30, 2012 | -164.78% |
| Jun 30, 2012 | -24.76% |
| Mar 31, 2012 | 351.07% |
| Dec 31, 2011 | 19.91% |
| Sep 30, 2011 | -45.73% |
| Jun 30, 2011 | -144.01% |
| Mar 31, 2011 | 263.14% |
| Dec 31, 2010 | 19.83% |